Forge Life Science Partners

Funding rounds backed by Forge Life Science Partners.

Export CSV
Funding disclosed in full
$228M
Median round
$75M
Rounds in calculation
3
3 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Khartis Therapeutics

Develops oral small molecule therapies for immunological and chronic diseases

$50MSeries BBiotechUnited States
6 participantsAlexandria Venture InvestmentsForesite CapitalForge Life Science PartnersLilly Asia VenturesLongwood FundNextech Invest
Infinimmune

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

$75MSeries ABiotechUnited States
11 participantsCivilization VenturesEverbright BiofundForge Life Science PartnersGodfrey CapitalGoldcrest CapitalMerck Global Health Innovation FundPear VCPlayground GlobalRA Capital ManagementRegeneron VenturesWild Tree Ventures
Kinaset Therapeutics

Develops inhaled therapies for severe respiratory diseases

$103MSeries BBiotechUnited States
11 participants5AM VenturesAtlas VentureEQT Life SciencesForge Life Science PartnersGimvPictet Alternative AdvisorsRA Capital ManagementSchroders CapitalSixty Degree CapitalVivo CapitalWillett Advisors